Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$9.37
-1.7%
$9.58
$9.17
$14.14
N/A0.33209,143 shs259,175 shs
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$30.29
-2.5%
$29.30
$23.69
$31.72
$13.27B0.69823,768 shs1.29 million shs
STERIS plc stock logo
STE
STERIS
$227.92
-1.2%
$238.49
$200.98
$252.79
$22.42B0.92550,422 shs431,175 shs
Demant A/S Unsponsored ADR stock logo
WILYY
Demant A/S
$20.98
$20.31
$15.03
$21.96
$8.97B0.9883 shs1 shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$93.88
-1.3%
$93.37
$89.22
$116.71
$18.57B0.711.82 million shs1.57 million shs
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
+0.63%+1.82%-1.65%-10.09%-25.20%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
+1.00%+2.60%+3.23%+20.13%+10.01%
STERIS plc stock logo
STE
STERIS
-0.42%-2.99%-4.88%+4.19%+7.04%
Demant A/S Unsponsored ADR stock logo
WILYY
Demant A/S
0.00%0.00%+1.32%+39.62%-4.46%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
-0.01%+1.58%+0.31%-6.99%-10.99%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
N/AN/AN/AN/AN/AN/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
3.7645 of 5 stars
1.05.02.50.03.30.04.4
STERIS plc stock logo
STE
STERIS
4.9053 of 5 stars
3.35.03.33.82.42.51.3
Demant A/S Unsponsored ADR stock logo
WILYY
Demant A/S
N/AN/AN/AN/AN/AN/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
4.9594 of 5 stars
3.25.02.53.73.32.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
2.40
HoldN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
2.00
Hold$28.00-7.94% Downside
STERIS plc stock logo
STE
STERIS
2.63
Moderate Buy$263.8315.44% Upside
Demant A/S Unsponsored ADR stock logo
WILYY
Demant A/S
3.20
BuyN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.32
Hold$110.0016.77% Upside

Current Analyst Ratings Breakdown

Latest STE, ZBH, SNN, WILYY, and CLPBY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/8/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$102.00 ➝ $96.00
6/20/2025
Demant A/S Unsponsored ADR stock logo
WILYY
Demant A/S
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
6/5/2025
Demant A/S Unsponsored ADR stock logo
WILYY
Demant A/S
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
5/29/2025
STERIS plc stock logo
STE
STERIS
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold$263.00
5/19/2025
STERIS plc stock logo
STE
STERIS
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$240.00 ➝ $260.00
5/16/2025
STERIS plc stock logo
STE
STERIS
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
5/16/2025
STERIS plc stock logo
STE
STERIS
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Outperform ➝ Market Outperform$265.00 ➝ $280.00
5/15/2025
STERIS plc stock logo
STE
STERIS
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$250.00 ➝ $250.00
5/12/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$115.00 ➝ $101.00
5/9/2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeModerate Buy ➝ Hold
5/7/2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$3.93BN/AN/AN/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$5.81B2.29$3.13 per share9.72$12.04 per share2.53
STERIS plc stock logo
STE
STERIS
$5.46B4.12$14.08 per share16.23$67.33 per share3.39
Demant A/S Unsponsored ADR stock logo
WILYY
Demant A/S
$3.25B2.76$0.95 per share22.11$3.16 per share6.64
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$7.68B2.43$13.05 per share7.22$62.67 per share1.50
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$734.56M$0.3031.2123.413.6016.38%27.29%9.40%8/19/2025 (Estimated)
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$412M$2.1614.0815.210.94N/AN/AN/A8/5/2025 (Estimated)
STERIS plc stock logo
STE
STERIS
$614.64M$6.2036.8723.02N/A11.26%14.21%9.13%8/5/2025 (Estimated)
Demant A/S Unsponsored ADR stock logo
WILYY
Demant A/S
$346.11MN/A0.0018.40N/AN/AN/AN/A8/12/2025 (Estimated)
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$903.70M$4.5220.8410.622.2011.86%12.73%7.34%8/6/2025 (Estimated)

Latest STE, ZBH, SNN, WILYY, and CLPBY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.99N/AN/AN/A$2.06 billionN/A
8/5/2025Q1 2026
STERIS plc stock logo
STE
STERIS
$2.32N/AN/AN/A$1.36 billionN/A
5/14/2025Q4 2025
STERIS plc stock logo
STE
STERIS
$2.59$2.74+$0.15$1.47$1.47 billion$1.48 billion
5/6/2025Q2 2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$0.0874$0.06-$0.0274$0.06$7.02 billion$1.05 billion
5/5/2025Q1 2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.77$1.81+$0.04$0.91$1.89 billion$1.91 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$0.080.85%N/A26.67%N/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$0.892.93%N/A41.20%N/A
STERIS plc stock logo
STE
STERIS
$2.281.00%N/A36.77%20 Years
Demant A/S Unsponsored ADR stock logo
WILYY
Demant A/S
N/AN/AN/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.961.02%N/A21.24%N/A

Latest STE, ZBH, SNN, WILYY, and CLPBY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/30/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.241.03%6/26/20256/26/20257/31/2025
5/7/2025
STERIS plc stock logo
STE
STERIS
quarterly$0.571.01%6/10/20256/10/20256/26/2025
5/16/2025
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
$0.03892.02%5/16/20255/19/20255/22/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
0.98
0.95
0.61
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.62
2.89
1.33
STERIS plc stock logo
STE
STERIS
0.29
1.96
1.39
Demant A/S Unsponsored ADR stock logo
WILYY
Demant A/S
1.29
1.63
1.22
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.53
2.44
1.46

Institutional Ownership

CompanyInstitutional Ownership
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
N/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
25.64%
STERIS plc stock logo
STE
STERIS
94.69%
Demant A/S Unsponsored ADR stock logo
WILYY
Demant A/S
N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
N/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
1.00%
STERIS plc stock logo
STE
STERIS
1.07%
Demant A/S Unsponsored ADR stock logo
WILYY
Demant A/S
N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
1.39%
CompanyEmployeesShares OutstandingFree FloatOptionable
Coloplast A/S Sponsored ADR stock logo
CLPBY
Coloplast A/S
16,875N/AN/ANot Optionable
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
17,349437.97 million433.59 millionOptionable
STERIS plc stock logo
STE
STERIS
17,78798.37 million97.32 millionOptionable
Demant A/S Unsponsored ADR stock logo
WILYY
Demant A/S
22,639427.59 millionN/ANot Optionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
17,000197.85 million195.10 millionOptionable

Recent News About These Companies

Getinge, Zimmer Biomet Announce Partnership In The ASC Sector
Zimmer Biomet, Getinge ink ASC partnership
Zimmer Biomet (NYSE:ZBH) Price Target Lowered to $96.00 at Evercore ISI
ZBH - Zimmer Biomet Holdings Inc Chart | Morningstar

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Coloplast A/S stock logo

Coloplast A/S OTCMKTS:CLPBY

$9.37 -0.16 (-1.68%)
As of 03:59 PM Eastern

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Smith & Nephew SNATS stock logo

Smith & Nephew SNATS NYSE:SNN

$30.29 -0.78 (-2.51%)
Closing price 03:59 PM Eastern
Extended Trading
$30.28 0.00 (-0.02%)
As of 04:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

STERIS stock logo

STERIS NYSE:STE

$227.92 -2.80 (-1.21%)
Closing price 03:59 PM Eastern
Extended Trading
$227.98 +0.06 (+0.03%)
As of 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Demant A/S stock logo

Demant A/S OTCMKTS:WILYY

$20.98 0.00 (0.00%)
As of 07/9/2025

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

Zimmer Biomet stock logo

Zimmer Biomet NYSE:ZBH

$93.88 -1.27 (-1.33%)
Closing price 03:59 PM Eastern
Extended Trading
$94.02 +0.14 (+0.15%)
As of 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.